Public opinion on global distribution of COVID-19 vaccines: Evidence from two nationally representative surveys in Germany and the United States.
COVID-19
Distributive justice
Global vaccination
Journal
Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899
Informations de publication
Date de publication:
06 04 2022
06 04 2022
Historique:
received:
03
12
2021
revised:
25
01
2022
accepted:
26
02
2022
pubmed:
21
3
2022
medline:
6
4
2022
entrez:
20
3
2022
Statut:
ppublish
Résumé
Despite ongoing calls for a more even global distribution of COVID-19 vaccines, there remains a great disparity between high- and low-income countries. We conducted representative surveys among the adult populations in the United States (N = 1,000) and Germany (N = 1,003) in June 2021 to assess public opinion in these countries on the distributive justice of COVID-19 vaccines. We conducted two instances of analytic hierarchy processes (AHP) to elicit how the public weighs different principles and criteria for vaccine allocation. In further discrete choice experiments, respondents were asked to split a limited supply of vaccine doses between a hypothetical high-income and a hypothetical low-income country. AHP weights in the United States and Germany were 37.4% (37.2-37.5) and 49.4% (49.2-49.5) for "medical urgency", 32.7% (32.6-32.8) and 25.4% (25.2-25.5) for "equal access for all", 13.7% (13.6-13.8) and 13.3% (13.2-13.4) for "production contribution", and 16.3% (16.2-16.4) and 12.0% (11.9-12.1) for "free market rules", respectively, with 95% CI shown in parentheses. In the discrete choice experiment, respondents in the United States and Germany split available vaccine doses such that the low-income country, which was three times more populous than the high-income country, on average received 53.9% (95% CI: 52.6-55.1) and 57.5% (95% CI: 56.3-58.7) of available doses, respectively. When faced with a dilemma where a vulnerable family member was waiting for a vaccine, 20.7% (95% CI: 18.2-23.3) of respondents in the United States and 18.2% (95% CI: 15.8-20.6) in Germany reduced the amount they allocated to the low-income country sufficiently to secure a vaccine for their family member. Our results indicate that the public in the United States and Germany favours utilitarian and egalitarian distribution principles of vaccines for COVID-19 over libertarian or meritocratic principles. This implies that political decisions favouring higher levels of redistribution would be supported by public opinion in these two countries.
Identifiants
pubmed: 35305827
pii: S0264-410X(22)00259-6
doi: 10.1016/j.vaccine.2022.02.084
pmc: PMC8890975
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2457-2461Informations de copyright
Copyright © 2022 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Nat Med. 2021 Aug;27(8):1385-1394
pubmed: 34272499
Nat Med. 2021 Jun;27(6):935-936
pubmed: 33785911
Vaccine. 2021 Apr 22;39(17):2452-2457
pubmed: 33745729
Science. 2020 Sep 11;369(6509):1309-1312
pubmed: 32883884
Lancet. 2021 Jun 19;397(10292):2322-2325
pubmed: 34147145
Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):23989-23995
pubmed: 31719198
BMJ. 2021 Jan 5;372:m4853
pubmed: 33402340
Lancet. 2015 Feb 14;385(9968):640-648
pubmed: 25468152
BMJ Glob Health. 2021 Feb;6(2):
pubmed: 33589419
JAMA. 2021 Apr 6;325(13):1261-1262
pubmed: 33571363
Lancet. 2021 Mar 13;397(10278):952-954
pubmed: 33581803
Glob Public Health. 2021 Oct 22;:1-17
pubmed: 34686103
Lancet. 2021 Mar 13;397(10278):1023-1034
pubmed: 33587887